Current address: Cara Therapeutics, Inc., Shelton, CT 06484, USA.
Reversal of acid-induced and inflammatory pain by the selective ASIC3 inhibitor, APETx2
Version of Record online: 9 JUN 2010
© 2010 Merck Sharp & Dohme Corp.. British Journal of Pharmacology © 2010 The British Pharmacological Society
British Journal of Pharmacology
Volume 161, Issue 4, pages 950–960, October 2010
How to Cite
Karczewski, J., Spencer, R. H., Garsky, V. M., Liang, A., Leitl, M. D., Cato, M. J., Cook, S. P., Kane, S. and Urban, M. O. (2010), Reversal of acid-induced and inflammatory pain by the selective ASIC3 inhibitor, APETx2. British Journal of Pharmacology, 161: 950–960. doi: 10.1111/j.1476-5381.2010.00918.x
- Issue online: 9 JUN 2010
- Version of Record online: 9 JUN 2010
- Accepted manuscript online: 9 JUN 2010 12:00AM EST
- Received12 February 2010Revised4 May 2010Accepted25 May 2010
Supporting Information: Teaching Materials; Figs 1–5 as PowerPoint slide.
|BPH_918_sm_Figs1-5.pptx||536K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.